Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Clin Pharmacol Ther. 2013 Oct;94(4):433-5. doi: 10.1038/clpt.2013.144.
Devices have become a cornerstone of heart failure (HF) therapy. Implantable cardioverter-defibrillators (ICDs) decrease mortality, and cardiac resynchronization therapy (CRT) improves symptoms and mortality. Most data have been collected in patients with systolic dysfunction. Data in patients with preserved systolic function are scarce, but interesting therapeutic concepts are evolving. Besides therapeutic functions, devices can have add-on diagnostic features such as early detection of fluid overload. In addition, stand-alone diagnostic devices are now also being developed for HF.
设备已成为心力衰竭(HF)治疗的基石。植入式心脏复律除颤器(ICD)可降低死亡率,心脏再同步治疗(CRT)可改善症状和死亡率。大多数数据都是在收缩功能障碍患者中收集的。关于保留收缩功能的患者的数据很少,但有趣的治疗概念正在不断发展。除了治疗功能外,设备还可以具有附加的诊断功能,例如早期发现体液过多。此外,现在也正在为 HF 开发独立的诊断设备。